WeVote

Bill

Bill

A 4810

Requires NJ FamilyCare reimbursement for comprehensive medication management services provided for certain children by licensed pharmacist.

2024-2025 Regular Session Introduced by Reginald Atkins and 4 co-sponsors

NJ FamilyCare must reimburse pharmacists for comprehensive medication management services provided to eligible children, expanding Medicaid coverage for clinical pharmacy services.

Reported and Referred to Assembly Appropriations Committee
0
WeVote Research Nonpartisan
Bill Summary · A 4810

Legislative bill overview

Bill A 4810 requires New Jersey's FamilyCare program (Medicaid) to reimburse licensed pharmacists for providing comprehensive medication management (CMM) services to eligible children. CMM involves reviewing medications for safety, effectiveness, and proper use, typically provided by pharmacists in clinical or community settings. The bill expands Medicaid coverage to include these pharmacist-delivered services for a pediatric population.

Why is this important

Medication errors and suboptimal drug therapy management are significant public health concerns, particularly for children with chronic conditions or complex medication regimens. This bill could improve medication safety and health outcomes while potentially reducing costly hospitalizations and emergency department visits. It also represents a policy shift recognizing pharmacists as clinical providers eligible for direct Medicaid reimbursement in New Jersey, which may expand access to medication management expertise beyond physician-only models.

Potential points of contention

  • Cost to state budget: FamilyCare reimbursement expansion increases Medicaid expenditures; fiscal impact depends on utilization rates and reimbursement rates not specified in the bill summary
  • Scope definition: "Comprehensive medication management services" is not precisely defined in available information, creating uncertainty about what services qualify and potential for billing disputes
  • Provider competition: Physicians and other prescribers may view this as encroachment on their traditional medication management role or concern about fragmented care coordination

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.